Auxiliary heterotopic liver transplantation with portal vein arterialization for fulminant hepatic failure

Carlos Margarit, Itxarone Bilbao, Ramón Charco, José Luis Lázaro, Ernest Hidalgo, Elena Allende, Enrique Murio

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

Abstract

Auxiliary liver transplantation for patients with fulminant hepatic failure supports the patient's failing liver for a period of time until the native liver (NL) has recovered and immunosuppression can be withdrawn. Auxiliary heterotopic liver transplantation (AHLT) with portal vein arterialization (PVA) has several advantages over auxiliary orthotopic liver transplantation: NL resection is not required, and the hepatic hilum is left untouched; thus, the chances of liver regeneration are optimal. The successful application of emergency AHLT with PVA in a young patient who developed toxic fulminant hepatic failure caused by tuberculostatic drugs is described. Two and one-half months after the procedure, the NL had completely regenerated; the graft was removed, and immuno-suppression was suspended.
Original languageEnglish
Pages (from-to)805-809
JournalLiver Transplantation
Volume6
Issue number6
DOIs
Publication statusPublished - 1 Jan 2000

Fingerprint Dive into the research topics of 'Auxiliary heterotopic liver transplantation with portal vein arterialization for fulminant hepatic failure'. Together they form a unique fingerprint.

Cite this